LA JOLLA PHARMACEUTICAL CO → TETRAPHASE PHARMACEUTICALS INC

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on TETRAPHASE PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2020-07-01	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2020-06-30	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2020-06-11	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2020-03-20	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2018-01-08	SC	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →

Other Filings by LA JOLLA PHARMACEUTICAL CO

Filed	Form	Issuer	Stake	Shares
2020-07-01	SC	TETRAPHASE PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →